TrialThe American journal of gastroenterology2014

First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses.

Max Karner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.